NO743077L - - Google Patents
Info
- Publication number
- NO743077L NO743077L NO743077A NO743077A NO743077L NO 743077 L NO743077 L NO 743077L NO 743077 A NO743077 A NO 743077A NO 743077 A NO743077 A NO 743077A NO 743077 L NO743077 L NO 743077L
- Authority
- NO
- Norway
- Prior art keywords
- prostate
- higher alkanol
- epithelium
- indicated
- process according
- Prior art date
Links
- 210000002307 prostate Anatomy 0.000 claims description 15
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- RHEVFAMQJMWLFS-UHFFFAOYSA-N icosan-2-ol Chemical compound CCCCCCCCCCCCCCCCCCC(C)O RHEVFAMQJMWLFS-UHFFFAOYSA-N 0.000 claims description 8
- 229960000735 docosanol Drugs 0.000 claims description 6
- 230000003248 secreting effect Effects 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- JXNPEDYJTDQORS-HZJYTTRNSA-N (9Z,12Z)-octadecadien-1-ol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCO JXNPEDYJTDQORS-HZJYTTRNSA-N 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 15
- 210000000981 epithelium Anatomy 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 8
- 238000002844 melting Methods 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- VUQPJRPDRDVQMN-UHFFFAOYSA-N 1-chlorooctadecane Chemical compound CCCCCCCCCCCCCCCCCCCl VUQPJRPDRDVQMN-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241001633635 Ademon Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 244000157072 Hylocereus undatus Species 0.000 description 1
- 235000018481 Hylocereus undatus Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010036940 Prostatic adenoma Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- KFEVDPWXEVUUMW-UHFFFAOYSA-N docosanoic acid Natural products CCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 KFEVDPWXEVUUMW-UHFFFAOYSA-N 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-N methyl undecanoic acid Natural products CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 1
- 238000004452 microanalysis Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 238000009519 pharmacological trial Methods 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
- C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
- C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
- C07C29/38—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones
- C07C29/40—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal by reaction with aldehydes or ketones with compounds containing carbon-to-metal bonds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4056873A GB1459233A (en) | 1973-08-29 | 1973-08-29 | Medicament containing a higher alkanol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO743077L true NO743077L (de) | 1975-03-24 |
Family
ID=10415549
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO743077A NO743077L (de) | 1973-08-29 | 1974-08-28 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4186211A (de) |
| JP (1) | JPS5076220A (de) |
| AR (1) | AR205721A1 (de) |
| BE (1) | BE819296A (de) |
| CA (1) | CA1036940A (de) |
| CH (1) | CH593218A5 (de) |
| DE (1) | DE2440436C3 (de) |
| DK (1) | DK456674A (de) |
| ES (1) | ES429585A1 (de) |
| FI (1) | FI251974A (de) |
| FR (1) | FR2242080B1 (de) |
| GB (1) | GB1459233A (de) |
| IE (1) | IE39671B1 (de) |
| IL (1) | IL45538A (de) |
| NL (1) | NL7411312A (de) |
| NO (1) | NO743077L (de) |
| SE (1) | SE7410889L (de) |
| ZA (1) | ZA745513B (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4209533A (en) | 1979-01-25 | 1980-06-24 | University Of Pittsburgh | Antibacterial agent and method |
| US4340628A (en) | 1979-01-25 | 1982-07-20 | Gilbertson John R | Antibacterial agent and method |
| US4372978A (en) | 1979-11-26 | 1983-02-08 | University Of Pittsburgh | Antibacterial agent and method |
| FR2532845B1 (fr) * | 1982-05-28 | 1988-01-15 | Eisai Co Ltd | Composition pharmaceutique comprenant a titre de principe actif le docosanol |
| DE3318989C2 (de) * | 1982-05-28 | 1996-11-21 | Eisai Co Ltd | ß,gamma-Dihydropolyprenylalkoholderivate und diese enthaltende Arzneimittel und deren Verwendung |
| DE3348493C2 (de) * | 1982-05-28 | 1998-09-17 | Eisai Co Ltd | Verwendung von Docosanol zur Behandlung und Prophylaxe von durch Immunmangelerscheinungen verursachten Infektionskrankheiten |
| IT1213176B (it) * | 1984-06-11 | 1989-12-14 | Milano A | Composizioni e composti per il trattamento dell'adenoma prostatico. |
| US5070107A (en) * | 1989-04-28 | 1991-12-03 | Lidak Pharmaceuticals | Systemic antiviral treatment |
| US5071879A (en) * | 1989-04-28 | 1991-12-10 | Lidak Pharmaceuticals | Systemic antiviral treatment |
| US5166219A (en) * | 1989-11-02 | 1992-11-24 | Lidak Pharmaceuticals | Systemic anti-inflammatory treatment |
| DK1473031T3 (da) * | 1993-12-13 | 2008-10-20 | Avanir Pharmaceuticals | Sucroseester - C20 til C28 alkoholformuleringer |
| US5952392A (en) * | 1996-09-17 | 1999-09-14 | Avanir Pharmaceuticals | Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition |
| US6440980B1 (en) * | 1996-09-17 | 2002-08-27 | Avanir Pharmaceuticals | Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| US5948822A (en) * | 1996-12-17 | 1999-09-07 | Lidak Pharmaceuticals | Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols |
| PT102410A (pt) * | 2000-02-03 | 2001-08-30 | Qualitas Lab | Extraccao da fraccao ceroide do residuo resinoso de fabricacao de aglomerado negro de cortica com fluido supercritico |
| WO2003032915A2 (en) * | 2001-10-16 | 2003-04-24 | Avanir Pharmacueticals | Viral inhibition by n-docosanol |
| US7214394B2 (en) * | 2002-05-31 | 2007-05-08 | Archer-Daniels-Midland Company | Policosanol compositions, extraction from novel sources, and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3031376A (en) * | 1956-10-11 | 1962-04-24 | Levin | Compositions comprising octacosanol, triacontanol, tetracosanol, or hexacosanol, andmethods employing same |
| US3226295A (en) * | 1960-02-08 | 1965-12-28 | Carlos C Goetz | Method of making cetyl alcohol emulsions |
| US3646215A (en) * | 1969-11-26 | 1972-02-29 | Commodity Improvements Inc | Heptadecanol for medical purposes |
| US3929869A (en) * | 1972-06-29 | 1975-12-30 | Labaz | Pentanol derivatives |
-
1973
- 1973-08-29 GB GB4056873A patent/GB1459233A/en not_active Expired
-
1974
- 1974-01-01 AR AR255339A patent/AR205721A1/es active
- 1974-08-20 FR FR7428617A patent/FR2242080B1/fr not_active Expired
- 1974-08-22 IE IE1744/74A patent/IE39671B1/xx unknown
- 1974-08-23 DE DE2440436A patent/DE2440436C3/de not_active Expired
- 1974-08-26 IL IL45538A patent/IL45538A/xx unknown
- 1974-08-26 CH CH1158774A patent/CH593218A5/xx not_active IP Right Cessation
- 1974-08-26 NL NL7411312A patent/NL7411312A/xx not_active Application Discontinuation
- 1974-08-27 ES ES429585A patent/ES429585A1/es not_active Expired
- 1974-08-27 CA CA207,936A patent/CA1036940A/en not_active Expired
- 1974-08-28 DK DK456674A patent/DK456674A/da not_active Application Discontinuation
- 1974-08-28 BE BE147990A patent/BE819296A/xx not_active IP Right Cessation
- 1974-08-28 FI FI2519/74A patent/FI251974A/fi unknown
- 1974-08-28 ZA ZA00745513A patent/ZA745513B/xx unknown
- 1974-08-28 SE SE7410889A patent/SE7410889L/xx unknown
- 1974-08-28 NO NO743077A patent/NO743077L/no unknown
- 1974-08-29 JP JP49098448A patent/JPS5076220A/ja active Pending
- 1974-08-30 US US05/502,036 patent/US4186211A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5076220A (de) | 1975-06-21 |
| SE7410889L (de) | 1975-03-03 |
| FR2242080B1 (de) | 1978-07-21 |
| CA1036940A (en) | 1978-08-22 |
| FR2242080A1 (de) | 1975-03-28 |
| BE819296A (fr) | 1974-12-16 |
| IL45538A (en) | 1978-06-15 |
| US4186211A (en) | 1980-01-29 |
| IL45538A0 (en) | 1974-11-29 |
| IE39671L (en) | 1975-02-28 |
| AR205721A1 (es) | 1976-05-31 |
| DE2440436A1 (de) | 1975-03-06 |
| DE2440436B2 (de) | 1981-02-26 |
| ZA745513B (en) | 1975-08-27 |
| DK456674A (de) | 1975-04-28 |
| IE39671B1 (en) | 1978-12-06 |
| GB1459233A (en) | 1976-12-22 |
| FI251974A (de) | 1975-03-01 |
| AU7277374A (en) | 1976-03-04 |
| NL7411312A (nl) | 1975-03-04 |
| ES429585A1 (es) | 1976-09-16 |
| CH593218A5 (de) | 1977-11-30 |
| DE2440436C3 (de) | 1982-03-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO743077L (de) | ||
| EP0637299B1 (de) | 20-methyl-substituierte vitamin d-derivate | |
| JPH11507649A (ja) | ２５位の炭素に置換基を有する新規なビタミンｄ誘導体、その製造方法、中間生成物及び薬剤の製造のためのその使用 | |
| CA1131215A (fr) | Procede de preparation de nouveaux derives 3,20-dioxo 4,9-diene 21-hydroxyle steroides | |
| EP0068055B1 (de) | Verfahren zur Herstellung eines dauerhaften, geruchlosen, antiprostatischen Extraktes aus Sabal-Serrulatum | |
| DE3141761A1 (de) | Nichtionische, oberflaechenaktive glucosederivate, verfahren zu deren herstellung, mittel, welche die neuen verbindungen enthalten sowie ein verfahren zu deren anwendung | |
| DE2147391C3 (de) | Verfahren zur Herstellung von 13- Äthyl-17 a -äthinyl-17 ß -hydroxy- 16 a -methylgona^-en-S-on | |
| EP0897302A2 (de) | Harpagosid-angereicherter extrakt aus harpagophytum procumbens und verfahren zu seiner herstellung | |
| EP1226155B1 (de) | 18-nor-steroide als selektiv wirksame estrogene | |
| EP0246504A2 (de) | Verfahren zur Herstellung einer Mischung eines Aldehyds mit dem entsprechenden Alkohol | |
| DE958837C (de) | Verfahren zur Herstellung von ambraartig riechendem 4,8,8-Trimethyl-9-methylenbicyclo-(1,3,3,)-nonanol-(4), dessen AEthern und Stereoisomeren | |
| DE2501091A1 (de) | 17-alpha-aethinyl-(5-alpha)-2-androsten-17-beta-ol und sein 17-beta-acetat, verfahren zu ihrer herstellung und ihre therapeutische verwendung | |
| Lin et al. | Electronic and steric influences on face selection during the oxy-Cope rearrangement of an. alpha.-allyl-. alpha.-vinylbenzyl alcohol | |
| EP0062903A1 (de) | 17-Alpha-Alkyl-17-beta-hydroxy-1-alpha-methyl-4-androsten-3-one, Verfahren zu ihrer Herstellung und pharmazeutische Präparate, die diese Verbindungen enthalten | |
| DE2145125A1 (de) | Prostansaurederivate und deren Her stellung | |
| EP1423407B1 (de) | 4-halogenierte 17-methylensteroide, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
| CA1052271A (en) | 1,2 - and 2,3 - epoxy alkanes | |
| JPH0229653B2 (ja) | Seiganzai | |
| RU2200165C1 (ru) | 17α-АЦЕТОКСИ-3β-ФЕНИЛПРОПИОНИЛОКСИ-6-МЕТИЛПРЕГНА-4,6-ДИЕН-20-ОН, ОБЛАДАЮЩИЙ ГЕСТАГЕННОЙ АКТИВНОСТЬЮ, И ЛЕКАРСТВЕННОЕ СРЕДСТВО НА ЕГО ОСНОВЕ | |
| DE2848463A1 (de) | Neue 17 alpha -aryl-steroid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| EP0011925A1 (de) | Naphthalin-Derivate, Verfahren zu ihrer Herstellung und Verwendung in entzündungshemmenden pharmazeutischen Zusammensetzungen | |
| US2089151A (en) | Process of preparing the hormone of suprarenal cortex | |
| AT269547B (de) | Verfahren zur Herstellung eines konzeptionsverhindernden Mittels für warmblütige Tiere | |
| JPH0794388B2 (ja) | 乾癬治療剤 | |
| US2068297A (en) | Oestrus-promoting substance from the anterior lobes of the hypophysis and process of preparing it |